pepinemab,nivolumab,ipilimumab
vaccinex,bms
['pepinemab', 'ipi/', 'nivo', 'triplet,(-triplete)', 'ipilimumab', 'nivolumab', 'melanoma']
neoadjuvant pepinemab in combination of nivolumab and/or ipilimumab in resectable stage iii melanoma. orr of 63% with the triplet but no ipi/nivo arm. does pepinemab provide extra benefit to the doublet? #esmo2022 #paris
28. MD. PhD student. Medical Oncology trainee at Ramón y Cajal University Hospital (Madrid). ES ????| EN ????| FR ????| ZH ????| ???? ??Avid traveller! ????